FCLKX
Price
$16.67
Change
+$0.16 (+0.97%)
Updated
Jun 6 closing price
Net Assets
60.5M
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

FCLKX vs VITSX

Header iconFCLKX vs VITSX Comparison
Open Charts FCLKX vs VITSXBanner chart's image
Fidelity Large Cap Stock K6
Price$16.67
Change+$0.16 (+0.97%)
VolumeN/A
Net Assets60.5M
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
FCLKX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FCLKX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCLKX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. FCLKX (60.5M). VITSX pays higher dividends than FCLKX: VITSX (1.29) vs FCLKX (1.11). FCLKX was incepted earlier than VITSX: FCLKX (8 years) vs VITSX (28 years). FCLKX (0.45) is less costly to investors than VITSX (0.03). FCLKX is a more actively managed with annual turnover of: 14.00 vs. VITSX (2.00). FCLKX has a lower initial minimum investment than VITSX: FCLKX (0) vs VITSX (5000000). FCLKX annual gain was more profitable for investors over the last year : 13.46 vs. VITSX (10.97). VITSX return over 5 years is better than : 80.96 vs. FCLKX (55.54).
FCLKXVITSXFCLKX / VITSX
Total Expense Ratio0.450.031,500%
Annual Report Gross Expense Ratio0.450.031,500%
Fund Existence8 years28 years-
Gain YTD6.9990.833840%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets60.5M1.82T0%
Annual Yield % from dividends1.111.2986%
Returns for 1 year13.4610.97123%
Returns for 3 years16.1940.3540%
Returns for 5 years55.5480.9669%
Returns for 10 yearsN/A180.49-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.